Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Librera OncoLink / Repaso de Diarios / Cáncer de Cólon y Recto
|
5-Fluorouracil-Induced Small Bowel Toxicity in Patients with Colorectal Carcinoma
Reviewers: Li Liu, MD Source: Cancer, Volume 86, No 7:1129-1134, October 1999.Background5-fluorouracil (5-FU) is used in the treatment of a variety of human malignancies either as single agent therapy or in combination with other antitumor agents.... |
|
|
A Comparison of Colonoscopy and Double-Contrast Barium Enema for Surveillance after Polypectomy
Reviewers: Li Liu, M.D Source: New England Journal of Medicine Volume 342 (24), 1766-1772 (June) 2000Précis: Colonoscopy is superior to barium enema for postpolypectomy surveillance.IntroductionIt is widely held that adenomatous polyps are... |
|
|
Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish rectal cancer trial
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Journal of Clinical Oncology 23:8697-8705, 2005. Introduction Radiation therapy and/or chemotherapy combined with surgery typically comprise the standard treatment for early to intermediate... |
|
|
Colorectal Cancer Screening and Surveillance Practices by Primary Care Physicians: Results of a National Survey
Reviewers: Li Liu, MD Source: The American Journal of Gastroenterology, Volume 95:1551-1556, (June) 2000.Précis: Colorectal cancer screening by many primary physicians may not be adequateIntroductionThe American Cancer Society and the... |
|
|
Conservative treatment of Rectal Adenocarcinoma with Endocavitary Irradiation or Wide Local Excision and Postoperative Irradiation
Reviewers: John Han-Chih Chang, M.D. and Kenneth Blank, M.D. Source: Journal of Clinical Oncology October 1997, Volume 15: pp 3241 - 8. BackgroundAlong with cure of the disease, sphincter (anal) preservation is an ultimate goal in the treatment in... |
|
|
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
Reviewers: Li Liu, MD Source: Annals of Internal Medicine, Volume 133:573-584, (October) 2000Précis: Colonoscopy is favored for colorectal cancer screeningIntroductionColorectal cancer is the second leading cause of death in North America.... |
|
|
Dietary fiber and the risk of colorectal cancer and adenoma in women
Reviewers: Kenneth Blank, MD Source: The New England Journal of the Medicine, January 21, 1999, Vol. 340 No. 3 p.169BackgroundAs we enter the final year of the 20th century, a look back reveals amazing strides in medicine: the advent of... |
|
|
Fecal Occult Blood Screening in the Minnesota Study: Role of Chance Detection of Lesions
Reviewers: Leonard A. Farber, M.D. and John Chang, M.D. Source: Journal of the National Cancer Institute 1997;89:1423-8 In the past, randomized trials have found that the mortality from colorectal cancer is reduced by periodic fecal occult blood... |
|
|
Guanylyl Cyclase C Messenger RNA is a Biomarker for Recurrent Stage II Colorectal Cancer
Reviewers: Li Liu, MD Source: Annals of Internal Medicine, 131(11): 805-812, December 1999.Précis: In this study, expression of guanylyl cyclase C mRNA appeared to be strongly associated with the presence of colorectal cancer micrometastases... |
|
|
Impact of a Clinical Guidelines Program for Breast and Colon Cancer in a French Cancer Center
Reviewers: John Han-Chih Chang, MD and Kenneth Blank, MD Source: The Journal of the American Medical Association 1997; Volume 278: pages 1591 - 95BackgroundIn most European countries, medical (especially cancer) care isusually centralized in a few... |
|
|
Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease
Reviewers: Kenneth Blank, MD and John Han-Chih Chang, MD Source: The New England Journal of Medicine, Volume 338 (21):1481Hereditary non-polyposis colorectal cancer (HNPCC) is a genetic disorder which, predisposes people to colon and other... |
|
|
Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial
Reviewers: John Han-Chih Chang, MDSource: Journal of Clinical Oncology Volume 17 (Number 8): pages 2396 - 2402BackgroundThere will be 56,000 colorectal cancers in the US in 1999. It remains the third leading cause of cancer deaths nationwide. ... |
|
|
Multicenter Phase II Study to Evaluate a 28-Day Regimen of Oral Fluorouracil Plus Eniluracil in the Treatment of Patients with Previously Untreated Metastatic Colorectal Cancer
Reviewers: Li Liu, MD Source: Journal of Clinical Oncology, Volume 18:2894-2901, (August) 2000Précis: Oral fluorouracil plus eniluracil is effective in treating metastatic colon cancerIntroductionFluorouracil (5-FU) has been a mainstay of... |
|
|
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Authors: Rolf Sauer MD, Heinz Becker MD, Werner Hohenberger MD, et al. for the German Rectal Cancer Study Group Source: New England Journal of Medicine 351(17): 1731-1340 (2004) Background Adjuvant radiotherapy (RT) with or without... |
|
|
Tumor Downstaging and Sphincter Preservation with Preoperative Chemoradiation in Locally advanced rectal cancer: The M. D. Anderson Cancer Center Experience
Reviewers: Li Liu, MD Source: International Journal of Radiation Oncology, Biology, and Physics, Volume 44, No 5 (July): 1027-1038, 1999.BackgroundNutritional support has long been known as an important part of multimodality treatment of head and... |
|
|
Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer
Reviewers: Li Liu, MD Source: New England Journal of Medicine, Volume 343(14): 162-168, (July) 2000.Précis: Colonoscopy is favored for colorectal cancer screening in asymptomatic adultsIntroductionAlmost all colorectal cancers arise from... |
Ms. Wagner discusses diet during cancer treatment and balancing nutritional needs and side effects. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

